Device Trial Radar · NCT03109964
The Affect of Hemostasis Technique During Laparoscopic Ovarian Cystectomy on Future Fertility
Last checked: Nov 19, 2026Latest source record: Oct 26, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
127
Actual
Start
Nov 20, 2018
Primary completion
Mar 31, 2021
Study completion Aug 1, 2022
Sponsor
- Lead sponsor
- Rambam Health Care CampusAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 12, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years, up to 44 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Patients undergoing elective laparoscopic ovarian cystectomy will be recruited and randomly divided into 2 groups according to intervention technique-half will be allocated to the bipolar coagulation group and half to the SURGIFLO group. Patients will be assessed both pre-operatively and 6 months post-operatively by blood tests including follicle stimulating hormone (FSH), lutenizing hormone (LH), Estrogen (E2), Progesterone and anti-mullerian hormone (AMH) levels, and sonographic evaluation of ovarian volume and antral follicle count.
Conditions
- Cyst Ovary
Interventions
Bipolar coagulation forceps (ETHICON inc.)Device
Hemostasis of the base of the ovarian cyst by utilization of a bipolar coagulation device.
SURGIFLO hemostatic matrix (ETHICON inc.)Device
Hemostasis of the base of the ovarian cyst by utilization of a an absorbable gelatin based matrix known as SURGIFLO.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Decline in ovarian reserve.Time frame: Up to 6 months.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rambam health care campus
Haifa, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.